tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

PMN Stock Latest News

ProMIS Neurosciences to showcase PMN310 at ICBN
The FlyProMIS Neurosciences to showcase PMN310 at ICBN
8d ago
PMN
ProMIS Neurosciences to Showcase PMN310’s Ability to Target Toxic Oligomers and Distinguish from Other Amyloid-Beta Oligomers in Preclinical Studies at the 4th International Conference on Cognitive & Behavioral Neurosciences
PremiumPress Releases
ProMIS Neurosciences to Showcase PMN310’s Ability to Target Toxic Oligomers and Distinguish from Other Amyloid-Beta Oligomers in Preclinical Studies at the 4th International Conference on Cognitive & Behavioral Neurosciences
8d ago
PMN
ProMIS Neurosciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference
PremiumPress Releases
ProMIS Neurosciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference
15d ago
PMN
ProMIS Neurosciences files to sell 56.51M common shares for holders
PremiumThe Fly
ProMIS Neurosciences files to sell 56.51M common shares for holders
22d ago
PMN
ProMIS Neurosciences reports Q2 EPS (13c) vs (27c) last year
PremiumThe Fly
ProMIS Neurosciences reports Q2 EPS (13c) vs (27c) last year
1M ago
PMN
ProMIS Neurosciences annouces data on pathogenic role of misfolded SOD1
PremiumThe FlyProMIS Neurosciences annouces data on pathogenic role of misfolded SOD1
2M ago
PMN
ProMIS Neurosciences to Participate in BTIG Virtual Biotechnology Conference 2024
Premium
Press Releases
ProMIS Neurosciences to Participate in BTIG Virtual Biotechnology Conference 2024
2M ago
PMN
ProMIS Neurosciences presents preclinical data on ABO at AAIC
Premium
The Fly
ProMIS Neurosciences presents preclinical data on ABO at AAIC
2M ago
PMN
ProMIS Neurosciences Showcases Novel Vaccine Approach for Maximal Targeting of Toxic Amyloid-Beta Oligomers at the 2024 Alzheimer’s Association International Conference
PremiumPress Releases
ProMIS Neurosciences Showcases Novel Vaccine Approach for Maximal Targeting of Toxic Amyloid-Beta Oligomers at the 2024 Alzheimer’s Association International Conference
2M ago
PMN
ProMIS Neurosciences Advances in Alzheimer’s Treatment Trial
PremiumCompany Announcements
ProMIS Neurosciences Advances in Alzheimer’s Treatment Trial
2M ago
8K
PMN
ProMIS Neurosciences announces up to $122.7M private placement financing
PremiumThe Fly
ProMIS Neurosciences announces up to $122.7M private placement financing
2M ago
PMN
ProMIS Neurosciences Reports Positive Top-Line Data from its Phase 1a Alzheimer’s Trial
PremiumPress Releases
ProMIS Neurosciences Reports Positive Top-Line Data from its Phase 1a Alzheimer’s Trial
2M ago
PMN
ProMIS Neurosciences reports data from its Phase 1a Alzheimer’s trial
PremiumThe FlyProMIS Neurosciences reports data from its Phase 1a Alzheimer’s trial
2M ago
PMN
ProMIS Neurosciences Announces Up to $122.7 Million Private Placement Financing
Premium
Press Releases
ProMIS Neurosciences Announces Up to $122.7 Million Private Placement Financing
2M ago
PMN
ProMIS Neurosciences Announces First Quarter 2024 Financial Results and Recent Highlights
Premium
Press Releases
ProMIS Neurosciences Announces First Quarter 2024 Financial Results and Recent Highlights
4M ago
PMN
ProMIS Neurosciences Advances Alzheimer’s Treatment with PMN310
PremiumCompany Announcements
ProMIS Neurosciences Advances Alzheimer’s Treatment with PMN310
5M ago
8K
PMN
ProMIS Neurosciences publishes study highlighting oligomers in journal bioRxiv
PremiumThe Fly
ProMIS Neurosciences publishes study highlighting oligomers in journal bioRxiv
5M ago
PMN
ProMIS Neurosciences Publishes Study Highlighting Oligomer Selectivity and Benefit of Amyloid-Beta-Directed Antibodies
PremiumPress Releases
ProMIS Neurosciences Publishes Study Highlighting Oligomer Selectivity and Benefit of Amyloid-Beta-Directed Antibodies
5M ago
PMN
ProMIS publishes data on pathogenic proteins as treatment target for ALS
PremiumThe Fly
ProMIS publishes data on pathogenic proteins as treatment target for ALS
5M ago
PMN
ProMIS Neurosciences to Present in Upcoming Investor Conferences in April 
PremiumPress ReleasesProMIS Neurosciences to Present in Upcoming Investor Conferences in April 
6M ago
PMN
ProMIS Neurosciences Announces Full Year 2023 Financial Results and Recent Highlights
Premium
Press Releases
ProMIS Neurosciences Announces Full Year 2023 Financial Results and Recent Highlights
6M ago
PMN
ProMIS Neurosciences strengthens global IP portfolio
Premium
The Fly
ProMIS Neurosciences strengthens global IP portfolio
6M ago
PMN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >